NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Clinical trials for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER explained in plain language.
Never miss a new study
Get alerted when new NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER trials appear
Sign up with your email to follow new studies for NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Milder chemo may make stem cell transplants safer for Non-Cancer patients
Disease control Recruiting nowThis phase 2 trial tests a combination of three chemotherapy drugs (treosulfan, fludarabine, thiotepa) plus an immune-suppressing antibody before a donor stem cell transplant in up to 40 people under 50 with non-cancerous blood disorders. The goal is to see if this milder conditi…
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can we predict blood cancer in ovarian cancer survivors?
Knowledge-focused Recruiting nowThis study follows 2,000 people who have had ovarian or other solid cancers to learn why some later develop blood cancers like leukemia. Researchers will look at genetic changes in blood cells and treatment history to identify risk factors. No new treatments are being tested—the …
Matched conditions: NON-NEOPLASTIC HEMATOPOIETIC AND LYMPHOID CELL DISORDER
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC